Management challenges in patients with comorbid COVID-19 associated delirium and serious mental illness - A case series.
Int J Psychiatry Med
; 56(4): 255-265, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1058157
ABSTRACT
BACKGROUND:
There is still a lot unknown about the novel Coronavirus Disease 19 (COVID-19) and its effects in humans. This pandemic has posed several challenging clinical situations to healthcare providers.OBJECTIVE:
We hope to highlight the distinctive challenges that COVID-19 presents in patients with serious mental illness and what steps primary medical teams can take to co-manage these patients with the psychiatry consultants.METHODS:
We present a retrospective chart review of four patients who were on psychotropic polypharmacy and admitted to our hospital from the same long-term psychiatric facility with COVID-19 delirium and other associated medical complications.RESULTS:
We illustrate how the primary medical teams and psychiatrists collaborated in clinical diagnosis, treatment, and management.CONCLUSIONS:
Patients with serious mental illness and COVID-19 infection require active collaboration between primary medical teams and psychiatrists for diagnostic clarification, reduction of psychotropic polypharmacy to avoid adverse effects and drug-drug interactions, prevention of psychiatric decompensation, and active management of agitation while balancing staff and patient safety concerns.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Trastornos Psicóticos
/
Esquizofrenia
/
Trastorno Bipolar
/
Delirio
/
COVID-19
Tipo de estudio:
Reporte de caso
/
Estudio observacional
/
Estudio pronóstico
Tópicos:
Covid persistente
Límite:
Femenino
/
Humanos
/
Masculino
/
Middle aged
Idioma:
Inglés
Revista:
Int J Psychiatry Med
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
0091217420985979
Similares
MEDLINE
...
LILACS
LIS